Skeletal Dysplasia_Fetal

Gene: HYLS1

Green List (high evidence)

HYLS1 (HYLS1, centriolar and ciliogenesis associated)
EnsemblGeneIds (GRCh38): ENSG00000198331
EnsemblGeneIds (GRCh37): ENSG00000198331
OMIM: 610693, Gene2Phenotype
HYLS1 is in 18 panels

3 reviews

Chirag Patel (Genetic Health Queensland)

Green List (high evidence)

ClinGen classification: Moderate
Skeletal anomalies seen as anomaly

HYLS1 was first reported in relation to autosomal recessive hydrolethalus in 2005 (Mee et al., PMID: 15843405). This is often a fatal fetal condition that results in stillbirth, or death shortly after birth. Prenatal features have been identified as early as the first trimester, and phenotypes include FGR (fetal growth restriction), brain anomalies, skeletal features (like femoral bowing and polydactyly/syndactyly), congenital heart disease, and genital anomalies. The most frequent features of this condition in probands with the founder missense mutation include hydrocephalus, small mandible, polydactyly, congenital heart defects, and respiratory anomalies. Affected probands compound heterozygous for the recurrent missense variant and another missense or nonsense variant have also been reported. Three variants (missense, nonsense) that have been reported in over 40 probands in 3 publications (PMIDs: 15843405, 18648327, 34212369) are included in this curation. The mechanism of pathogenicity appears to be loss-of-function. There were also two homozygous stop loss variants reported in 2 probands from 2 publications (PMID: 26830932, 36580738), but these were not scored because the phenotype does not fully match that of the other cases and and their disease mechanism similarity cannot be confirmed. This gene-disease relationship is also supported by experimental evidence (mouse model, drosophila model, expression-level data, interaction evidence, cell culture evidence, functional alteration evidence; PMIDs: 15843405, 19656802, 32509774, 40009365). Homozygous mutant mice exhibit perinatal lethality, brain anomaly, polydactyly, and kidney complications. The drosophila model showed ciliary dysfunction and atypical spermatogenesis in mutants. The gene is widely expressed in mice, including in specific brain regions such as the medulla. HYLS1 interacts with SAS-4 (CENPJ), which is definitively associated with autosomal recessive microcephaly 6 with/without short stature. Other experimental evidence indicates the key role of HYLS1 in centriole stability and ciliogenesis. In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Prenatal GCEP on the meeting date 8/06/2025 (SOP Version 11).
Created: 14 Aug 2025, 11:32 p.m. | Last Modified: 14 Aug 2025, 11:32 p.m.
Panel Version: 0.232

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Hydrolethalus syndrome MONDO:0006037

Zornitza Stark (Victorian Clinical Genetics Services)

I don't know

A recurring homozygous missense variant p.Asp211Gly has been identified in at least 64 cases of hydrolethalus syndrome, described as a Finnish founder mutation (PMID: 15843405, PMID: 18648327). Functional studies in human and patient cells have shown mislocalisation of the protein to the nucleus (PMID: 15843405, PMID: 19400947). Functional studies in c. elegans showed that this variant impaired ciliogenesis (PMID: 19656802). Functional studies in drosophila showed that deletion of HYLS1 led to cilia dysfunction (PMID: 32509774). 2 homozygous living siblings (stop-loss, extension variant p.Ter300TyrextTer11) both diagnosed with Joubert syndrome. Patients had molar tooth signs and dysplasia of cerebellar vermis (PMID: 26830932). No other variants have been reported as pathogenic in this gene. Amber rating on this panel as skeletal abnormalities including polydactyly and deformity of the skull base only described in those with the hydrolethalus phenotype, single founder variant and supporting functional data from multiple animal models all indicative of ciliopathy.
Created: 7 Aug 2020, 12:10 a.m. | Last Modified: 7 Aug 2020, 12:10 a.m.
Panel Version: 0.24

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Hydrolethalus syndrome (MIM#236680)

Publications

Elena Savva (Victorian Clinical Genetics Services)

I don't know

PMID: 34212369 - additional two fetuses with a phenotype of HLS with brain abnormalities, limbs malformations with pre and postaxial hexadactyly and abnormal genitalia. Probands were het for the Finnish founder variant (p.Asp211Gly) but each chet with a novel variant (p.(Arg221Pro, p.(Arg205*)). One fetus had occipital meningocele
molar tooth sign, the other craniorachischisis
Created: 16 Feb 2024, 4:54 a.m. | Last Modified: 16 Feb 2024, 4:54 a.m.
Panel Version: 0.212
OMIM notes Dandy Walker anomaly as a neurological feature. All patients results in either stillbirths or neonatal death, so limited information available. Almost all patients have the same recurring missense (p.Asp211Gly)

PMID: 18648327 - describes many patients with the recurring missense mutation. Summary table describes brain features of 19 patients, none appear to be consistent with JS

PMID: 26830932 - 2 homozygous living siblings (stop-loss, extension) both diagnosed with JS. Patients had molar tooth signs and dysplasia of cerebellar vermis

Single reported family, but likely due to a unique mutational spectrum separate from the recurring missense
Sources: Expert list
Created: 13 May 2020, 2:26 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Hydrolethalus syndrome MIM#236680

Publications

History Filter Activity

14 Aug 2025, Gel status: 3

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: hyls1 has been classified as Green List (High Evidence).

16 Feb 2024, Gel status: 2

Set publications

Elena Savva (Victorian Clinical Genetics Services)

Publications for gene: HYLS1 were set to 15843405; 18648327; 19400947; 19656802; 32509774; 26830932

7 Aug 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: hyls1 has been classified as Amber List (Moderate Evidence).

7 Aug 2020, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: HYLS1 were changed from to Hydrolethalus syndrome (MIM#236680)

7 Aug 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: HYLS1 were set to

7 Aug 2020, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: HYLS1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

7 Aug 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: hyls1 has been classified as Amber List (Moderate Evidence).

7 Aug 2020, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag founder tag was added to gene: HYLS1.

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: HYLS1 was added gene: HYLS1 was added to Skeletal dysplasia Fetal_MelbourneGenomics_VCGS. Sources: Melbourne Genomics Health Alliance Perinatal Autopsy Flagship,Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: HYLS1 was set to Unknown